Showing results (1051-1060 of 1,083) with videos related to

Sort By:
Pageof 109
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 7, 2024
Multidisciplinary team quality improves the survival outcomes of locally advanced rectal cancer patients: A post hoc analysis of the STELLAR trialHuiying Ma, Haoyue Li, Tongzhen Xu, et al.
Zhongguo Zhong Yao Za Zhi = Zhongguo Zhongyao Zazhi = China Journal of Chinese Materia Medica|December 6, 2022
[Reflections on supervision strategies of new Tibetan drug registration]Dan Liang, Tsring Pemba, Jiang-Yong Yu, et al.
BMC Cancer|January 25, 2023
Risk stratification and prognostic value of multi-modal MRI-based radiomics for extranodal nasal-type NK/T-cell lymphomaYu-Ting Zhao, Si-Ye Chen, Xin Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 12, 2020
Hypofractionated Versus Conventional Fractionated Radiotherapy After Breast-Conserving Surgery in the Modern Treatment Era: A Multicenter, Randomized Controlled Trial From ChinaShu-Lian Wang, Hui Fang, Chen Hu, et al.
International Journal of Radiation Oncology, Biology, Physics|March 31, 2023
Dose-Volume Predictors for Radiation Esophagitis in Patients With Breast Cancer Undergoing Hypofractionated Regional Nodal Radiation TherapyDan-Qiong Wang, Na Zhang, Li-Hua Dong, et al.
JAMA Network Open|November 30, 2021
Postoperative Chemoradiotherapy With Capecitabine and Oxaliplatin vs Capecitabine for Stage II to III Rectal Cancer: A Randomized Clinical TrialNing Li, Yuan Zhu, Lu-Ying Liu, et al.
Theranostics|January 27, 2021
Inhibition of miR-331-3p and miR-9-5p ameliorates Alzheimer's disease by enhancing autophagyMeng-Lu Chen, Chun-Gu Hong, Tao Yue, et al.
BMC Medicine|February 26, 2026
Minimum 18-week chemotherapy improves survival in locally advanced rectal cancer after neoadjuvant radiotherapy: a post hoc analysis of the STELLAR trialTongzhen Xu, Huiying Ma, Wenjue Zhang, et al.
The Lancet. Haematology|May 5, 2025
Low-dose moderate hypofractionated radiotherapy for indolent non-Hodgkin lymphoma: a multicentre, single-arm, phase 2 trialXin-Yue Wang, Xi-Mei Zhang, Liang Wang, et al.
Frontiers in Oncology|May 16, 2022
Preoperative Concurrent Chemoradiotherapy Versus Neoadjuvant Chemotherapy for Locally Advanced Gastric Cancer: Phase II Randomized StudyXin Wang, Dong-Bing Zhao, Lin Yang, et al.
Pageof 109